Jen focuses on counseling technology and life sciences clients. She represents companies and underwriters in public offerings and counsels public and late-stage private companies with respect to corporate and securities law compliance and disclosure matters.

Prior to joining Fenwick, Jen was an associate at a leading international law office in its Palo Alto office.

  • Representative Experience
    • Peloton in its $1.2B initial public offering
    • Fitbit in its $841M initial public offering and $567M follow-on offering, as well as in its $2.1B acquisition by Google
    • Adaptive Biotechnologies in its $345M initial public offering
    • Nurix in its $209M initial public offering
    • Dermira in its $111M and $145M follow-on offerings, as well as in $1.1B acquisition by Lilly
    • Agilent Technologies in its $300M notes offering
    • Cisco in its $7B notes offering
    • Underwriters led by Morgan Stanley, RBC Capital Markets, Pacific Crest Securities, a division of KeyBanc Capital Markets, and Piper Jaffray in the $77M initial public offering and $109M follow-on offering of Impinj
    • Underwriters led by Morgan Stanley, J.P. Morgan Securities, Allen & Company and UBS Securities in the $132M initial public offering of New Relic

Representative Clients

  • Fitbit
  • Goldman Sachs
  • JPMorgan
  • Morgan Stanley
  • Nurix Therapeutics
  • Peloton

Education & Admissions

J.D., with honors
University of California, Berkeley School of Law
Order of the Coif

B.A., summa cum laude, International Studies
University of California, San Diego

Admitted to practice in California

Login

Don’t have an account yet?

Register